TRIM21 and colorectal carcinoma: Furthermore, immunohistochemical (IHC) staining on human CRC tissue microarray (Cohort 2) demonstrated no significant difference in the distribution of clinicopathological characteristics between groups with low (immunoreactive score [IRS] ≤4) and high (IRS > 4) TRIM21 expression (Supplementary Table 1).